Citation Impact
1 from Science/Nature 16 standout
Citing Papers
Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics
2024 Standout
Works of Cameron Durrant being referenced
C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial
2022
Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia
2020
Author Peers
| Author | Epidemiology | Infectious Diseases | Genetics | Hematology | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Cameron Durrant | 11 | 9 | 21 | 27 | 17 | 13 | 78 | |
| Namiki Toyama | 4 | 10 | 578 | 14 | 815 | |||
| Setsuko Irie | 23 | 32 | 661 | |||||
| Regine Herbst‐Irmer | 11 | 17 | 728 | |||||
| Margit Cichna‐Markl | 69 | 37 | 15 | 12 | 956 | 90 | 2.1k | |
| James Syce | 47 | 28 | 2 | 5 | 182 | 27 | 706 |
All Works
Loading papers...